Sep 20, 2018 08:06PM Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock

Jun 12, 2018 07:05AM Viking Therapeutics Announces Closing of Public Offering of Common Stock

Jun 7, 2018 08:31AM Viking Therapeutics (VKTX) Prices 7.5M Common Stock Offering at $9/Share

Jun 7, 2018 08:30AM Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock

Jun 1, 2018 11:10AM Viking Therapeutic (VKTX) PT Raised to $13 at Roth Capital

Jun 1, 2018 09:23AM Pre-Open Movers 06/01: (LULU) (VKTX) (TTOO) Higher; (BIG) (CAL) (FULT) Lower (more...)

Mar 8, 2018 08:17AM Viking Therapeutic (VKTX) PT Raised to $7.50 at Roth Capital

Feb 6, 2018 04:05PM Viking Therapeutics Announces Closing of Public Offering of Common Stock

Feb 2, 2018 08:34AM Viking Therapeutics (VKTX) Prices 11M Shares at $5

Feb 2, 2018 08:33AM Viking Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock

Dec 11, 2017 04:15PM Viking Therapeutics Announces Closing of Public Offering of Common Stock

Dec 7, 2017 05:38AM Viking Therapeutics (VKTX) Prices 5.13M Share Offering at $2.50/Sh

Dec 6, 2017 08:08PM Viking Therapeutics Announces Pricing of $12.8 Million Public Offering of Common Stock

Nov 21, 2017 09:03AM Roth Capital Starts Viking Therapeutic (VKTX) at Buy

Jun 14, 2017 09:56AM Viking Therapeutics (VKTX) Enters $4.3M Registered Direct Offering

Jun 14, 2017 09:55AM Viking Therapeutics Announces $4.3 Million Registered Direct Offering

Jul 29, 2015 03:01PM Ligand Pharma (LGND) Becomes 'Value Play' as Viking (VKTX) Advances VK2809 - Roth Capital

Jun 5, 2015 08:40AM Roth Capital Raised Price Target Following Ligand Pharma (LGND) Receipt of Milestone Payment